| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ADURO BIOTECH | 2,106,734 | 63,897,000 | 22.42% | ||
| 2 | ADAPTIMMUNE THERAPEUTICS PLC | 1,757,268 | 32,211,000 | 11.30% | ||
| 3 | UNIVERSAL AMERN CORP NEW | 2,814,883 | 28,487,000 | 10.00% | ||
| 4 | ZAFGEN INC COM | 811,300 | 28,095,000 | 9.86% | ||
| 5 | EPIZYME INC COM | 897,863 | 21,549,000 | 7.56% | ||
| 6 | Orexigen Therapeutics, Inc. | 4,200,047 | 20,790,000 | 7.30% | ||
| 7 | Alder Biopharmaceutl | 344,770 | 18,262,000 | 6.41% | ||
| 8 | AERIE PHARMACEUTICALS INC | 805,217 | 14,212,000 | 4.99% | ||
| 9 | REGULUS THERAPEUTICS INC | 893,781 | 9,796,000 | 3.44% | ||
| 10 | ARDELYX INC | 517,290 | 8,261,000 | 2.90% | ||
| 11 | NANOSTRING TECHNOLOGIES INC | 464,486 | 7,162,000 | 2.51% | ||
| 12 | BioDelivery Sciences International Inc | 712,278 | 5,670,000 | 1.99% | ||
| 13 | SCYNEXIS INC | 628,155 | 5,521,000 | 1.94% | ||
| 14 | JUNO THERAPEUTICS INCORPORATED | 91,575 | 4,884,000 | 1.71% | ||
| 15 | QUOTIENT LTD | 298,360 | 4,413,000 | 1.55% | ||
| 16 | Biotie Therapies Corp. | 188,900 | 3,772,000 | 1.32% | ||
| 17 | NEXVET BIOPHARMA PUB LTD CO | 708,332 | 3,520,000 | 1.24% | ||
| 18 | AXOVANT SCIENCES LTD | 65,000 | 1,325,000 | 0.46% | ||
| 19 | NEURODERM LTD | 74,385 | 1,142,000 | 0.40% | ||
| 20 | ACCELERON PHARMA | 31,100 | 984,000 | 0.35% | ||
| 21 | Orexigen Therapeutics, Inc. | 120,000 | 594,000 | 0.21% | Call | |
| 22 | Agile Therapeutics, Inc. | 49,870 | 428,000 | 0.15% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-049188, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
